Parkman Healthcare Partners’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.07M | Buy |
|
|||||
|
2025
Q2 | $4.71M | Sell |
|
|||||
|
2025
Q1 | $5.86M | Sell |
|
|||||
|
2024
Q4 | $7.57M | Buy |
|
|||||
|
2024
Q3 | $7.55M | Sell |
|
|||||
|
2024
Q2 | $8.16M | Sell |
|
|||||
|
2024
Q1 | $9.64M | Sell |
|
|||||
|
2023
Q4 | $13.6M | Buy |
|
|||||
|
2023
Q3 | $7.4M | Sell |
|
|||||
|
2023
Q2 | $8.38M | Sell |
|
|||||
|
2023
Q1 | $9.92M | Buy |
|
|||||
|
2022
Q4 | $9.29M | Buy |
|
|||||
|
2022
Q3 | $8.04M | Sell |
|
|||||
|
2022
Q2 | $8.96M | Sell |
|
|||||
|
2022
Q1 | $9.3M | Sell |
|
|||||
|
2021
Q4 | $11.3M | Buy |
|
|||||
|
2021
Q3 | $4.75M | Sell |
|
|||||
|
2021
Q2 | $7.47M | Buy |
|
|||||
|
2021
Q1 | $6.7M | Buy |
|
|||||
|
2020
Q4 | $5.56M | Sell |
|
|||||
|
2020
Q3 | $5.15M | Sell |
|
|||||
|
2020
Q2 | $7.4M | Hold |
|
|||||
|
2020
Q1 | $6.69M | Buy |
|
|||||
|
2019
Q4 | $7.71M | Buy |
|